Previous studies have demonstrated that high FAP expression is associated with an increased risk of metastases and poor survival in CRC and thus proposed FAP as a possible biomarker for disease progression [4, 8, 17, 18]. The gene discussed is FAP; the disease is colorectal carcinoma.